BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL
...UEIUA43HWRNXFS3·Profile updated 2026-05-13
Awards tracked
1
Total amount
$92.5M
Date range
—
Primary sector
—
Volume
—
$/month, last 24
About this recipient
BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL has received $92.5M in tracked federal funding across the ingest window.
The largest single source of funding is Department of Health and Human Services, which dominates the recipient's federal portfolio. We surface the full breakdown of contracts and grants below.
A longer, LLM-generated profile becomes available for the top entities by total $ awarded. We do not take editorial direction from recipients.
Portfolio by sector
Sectors classified by LLM on each award.
- unclassified1 award$92.5M 100%
Portfolio status
Based on each award's period of performance.
Active
1
active100% of awards
Expiring (≤90d)
0
expiring · 30d0% of awards
Expired
0
expired0% of awards
No POP
0
—0% of awards
Top awarding agencies
Department of Health and Human Services
$92.5M 100%
Based on 1 awards totaling $92,501,232.
Awards
Top 1 by amount
| Action date | Recipient | Agency | Amount | Description | Sector | Status |
|---|---|---|---|---|---|---|
| — | BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL | Department of Health and Human Services | $92,501,232 | THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFECTIONS - OTA | — | active |
Sources
USAspending.gov — all awards for this UEI →SAM.gov entity registration →
Profile compiled from publicly available USAspending.gov records, ingested and entity-resolved by The Buildout's pipeline.